Richard E. Sutton

Development of an efficient reproducible cell-cell transmission assay for rapid quantification of SARS-CoV-2 spike interaction with hACE2

S. Farhadian, C. D. Dela Cruz, Sidi Chen, 2022, Cell Reports Methods.

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters

A. Gruber, R. Bartenschlager, P. Chlanda, 2022, mBio.

A cross-organism framework for supervised enhancer prediction with epigenetic pattern recognition and targeted validation

Mark Gerstein, Chengfei Yan, Axel Visel, 2018, bioRxiv.

Cell-based and cell-free firefly luciferase complementation assay to quantify Human Immunodeficiency Virus type 1 Rev-Rev interaction

Min Zhao, Richard E. Sutton, Jodie I. Baris, 2021, bioRxiv.

Supervised enhancer prediction with epigenetic pattern recognition and targeted validation

Kevin Y. Yip, Tyler H. Garvin, M. Gerstein, 2018, Nature Methods.

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617

Ryan D. Chow, Madeleine C. Mankowski, M. Diamond, 2022, Nature communications.

Serum Neutralizing Antibody Titers 12 Months After COVID-19 Messenger RNA Vaccination: Correlation to Clinical Variables in an Adult, US Population

Jingxuan Xu, Min Zhao, T. Kyriakides, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)

Shaili Gupta, O. Ogbuagu, Heidi J. Zapata, 2022, BMC Infectious Diseases.